Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2

The spread of the novel coronavirus (SARS-CoV-2) has triggered a global emergency, that demands urgent solutions for detection and therapy to prevent escalating health, social, and economic impacts. The spike protein (S) of this virus enables binding to the human receptor ACE2, and hence presents a prime target for vaccines preventing viral entry into host cells. The S proteins from SARS and SARS-CoV-2 are similar, but structural differences in the receptor binding domain (RBD) preclude the use of SARS-specific neutralizing antibodies to inhibit SARS-CoV-2. Here we used comparative pangenomic analysis of all sequenced reference Betacoronaviruses, complemented with functional and structural analyses. This analysis reveals that, among all core gene clusters present in these viruses, the envelope protein E shows a variant cluster shared by SARS and SARS-CoV-2 with two completely-conserved key functional features, namely an ion-channel, and a PDZ-binding motif (PBM). These features play a key role in the activation of the inflammasome causing the acute respiratory distress syndrome, the leading cause of death in SARS and SARS-CoV-2 infections. Together with functional pangenomic analysis, mutation tracking, and previous evidence, on E protein as a determinant of pathogenicity in SARS, we suggest E protein as an alternative therapeutic target to be considered for further studies to reduce complications of SARS-CoV-2 infections in COVID-19.

[1]  Gengfu Xiao,et al.  SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target , 2020, Cell Research.

[2]  Ramakrishna Vadde,et al.  In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel , 2020, Journal of biomolecular structure & dynamics.

[3]  Jun Wang,et al.  Put a cork in it: Plugging the M2 viral ion channel to sink influenza , 2020, Antiviral Research.

[4]  M. L. Serrano,et al.  Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis , 2020, EXCLI journal.

[5]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[6]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[7]  P. Niu,et al.  Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China , 2020, Cell Host & Microbe.

[8]  W. Liu,et al.  Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV , 2020, Chembiochem : a European journal of chemical biology.

[9]  R. Kruse.  Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China , 2020, F1000Research.

[10]  Ralph S. Baric,et al.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.

[11]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[12]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  R. Baric,et al.  Receptor recognition by novel coronavirus from Wuhan: 2 An analysis based on decade-long structural studies of SARS 3 , 2020 .

[14]  D. Baker,et al.  De novo design of a homo-trimeric amantadine-binding protein , 2019, eLife.

[15]  J. Chou,et al.  Critical Effect of Detergent:Protein Ratio on the Formation of Hepatitis C Virus p7 Channel. , 2019, Biochemistry.

[16]  T. Santos-Mendoza,et al.  Viral targeting of PDZ polarity proteins in the immune system as a potential evasion mechanism , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  B. Fielding,et al.  Coronavirus envelope protein: current knowledge , 2019, Virology Journal.

[18]  Maxat Kulmanov,et al.  DeepGOPlus: improved protein function prediction from sequence , 2019, bioRxiv.

[19]  Konstantinos D. Tsirigos,et al.  SignalP 5.0 improves signal peptide predictions using deep neural networks , 2019, Nature Biotechnology.

[20]  J. Chou,et al.  Critical E ff ect of the Detergent : Protein Ratio on the Formation of the Hepatitis C Virus p 7 Channel , 2019 .

[21]  Re-evaluating the p7 viroporin structure , 2018, Nature.

[22]  S. Perlman,et al.  Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis , 2018, mBio.

[23]  Torsten Schwede,et al.  SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..

[24]  Yan Li,et al.  Structural model of the SARS coronavirus E channel in LMPG micelles , 2018, Biochimica et Biophysica Acta (BBA) - Biomembranes.

[25]  M. Taghdir,et al.  Understanding the inhibitory mechanism of BIT225 drug against p7 viroporin using computational study. , 2018, Biophysical chemistry.

[26]  Richard A Neher,et al.  panX: pan-genome analysis and exploration , 2016, bioRxiv.

[27]  Fang Li,et al.  Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.

[28]  Luis Carrasco,et al.  Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals? , 2015, Viruses.

[29]  S. Perlman,et al.  Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates , 2015, Journal of Virology.

[30]  L. Enjuanes,et al.  The PDZ-Binding Motif of Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Is a Determinant of Viral Pathogenesis , 2014, PLoS pathogens.

[31]  J. Torres,et al.  Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis , 2014, PLoS pathogens.

[32]  Vladimir B. Bajic,et al.  INDIGO – INtegrated Data Warehouse of MIcrobial GenOmes with Examples from the Red Sea Extremophiles , 2013, PloS one.

[33]  S. Perlman,et al.  Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival , 2013, Journal of Virology.

[34]  Bing Sun,et al.  Unusual architecture of the p7 channel from hepatitis C virus , 2013, Nature.

[35]  Luis Carrasco,et al.  Viroporins: structure and biological functions , 2012, Nature Reviews Microbiology.

[36]  Yang Zhang,et al.  Ab initio protein structure assembly using continuous structure fragments and optimized knowledge‐based force field , 2012, Proteins.

[37]  Faizan Ahmad,et al.  The SARS Coronavirus 3a Protein Causes Endoplasmic Reticulum Stress and Induces Ligand-Independent Downregulation of the Type 1 Interferon Receptor , 2009, PloS one.

[38]  J. Torres,et al.  Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel , 2009, PLoS pathogens.

[39]  R. Baric,et al.  A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters , 2008, Journal of Virology.

[40]  Vikas Nanda,et al.  Structural basis for the function and inhibition of an influenza virus proton channel , 2008, Nature.

[41]  K. Subbarao,et al.  A Severe Acute Respiratory Syndrome Coronavirus That Lacks the E Gene Is Attenuated In Vitro and In Vivo , 2006, Journal of Virology.

[42]  P. Masters,et al.  The Molecular Biology of Coronaviruses , 2006, Advances in Virus Research.

[43]  P. Gage,et al.  Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication , 2006, Virology.

[44]  Matthias Stoldt,et al.  Solution structure of the X4 protein coded by the SARS related coronavirus reveals an immunoglobulin like fold and suggests a binding activity to integrin I domains , 2005, Journal of biomedical science.

[45]  J. Tam,et al.  Viroporin Activity of SARS-CoV E Protein , 2006, Advances in experimental medicine and biology.

[46]  H. Doerr,et al.  Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus , 2003, The Lancet.